Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer

NCT05406674 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

FIGO Stage III Ovarian Cancer
Peritoneal Cancer
Fallopian Tube Carcinoma

Interventions

DRUG: Cisplatin 100 mg/m2
DRUG: Cisplatin 40 mg/l

Sponsor

The Netherlands Cancer Institute